We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$310B
AUM Growth
+$8.85B
Cap. Flow
-$12.9B
Cap. Flow %
-4.15%
Top 10 Hldgs %
14.55%
Holding
10,459
New
1,343
Increased
3,599
Reduced
4,168
Closed
927

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Financials 7.38%
3 Consumer Discretionary 6.3%
4 Healthcare 6.09%
5 Communication Services 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WNW icon
7701
Meiwu Technology Co
WNW
$68.5M
0
ZNTL icon
7702
Zentalis Pharmaceuticals
ZNTL
$344M
$14K ﹤0.01%
+255
New +$13.7K
TEN
7703
Tsakos Energy Navigation Ltd
TEN
$1.16B
$14K ﹤0.01%
1,593
+1,573
+7,865% +$14.4K
IMG
7704
DELISTED
CIMG Inc
IMG
$14K ﹤0.01%
6
+3
+100% +$6.74K
TBIO
7705
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$14K ﹤0.01%
+35
New +$12.4K
ASLN
7706
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$14K ﹤0.01%
107
+92
+613% +$11.5K
TCON
7707
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$14K ﹤0.01%
110
-32
-23% -$4.43K
GENE
7708
DELISTED
Genetic Technologies Ltd.
GENE
$14K ﹤0.01%
697
+498
+250% +$10K
FLME.U
7709
DELISTED
Flame Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one Warrant
FLME.U
$14K ﹤0.01%
+1,400
New +$14K
CPTK.U
7710
DELISTED
Crown PropTech Acquisitions Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CPTK.U
$14K ﹤0.01%
1,449
-50
-3% -$497
EQRX
7711
DELISTED
EQRx, Inc. Common Stock
EQRX
$14K ﹤0.01%
+1,351
New +$13.8K
MTACU
7712
DELISTED
MedTech Acquisition Corporation Unit
MTACU
$14K ﹤0.01%
+1,378
New +$13.9K
ARBGU
7713
DELISTED
Aequi Acquisition Corp Unit
ARBGU
$14K ﹤0.01%
1,418
-963
-40% -$9.65K
CPUH.U
7714
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
$14K ﹤0.01%
1,407
-359
-20% -$3.63K
EUCRU
7715
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$14K ﹤0.01%
1,378
-1,300
-49% -$13.1K
DHHCU
7716
DELISTED
DiamondHead Holdings Corp. Unit
DHHCU
$14K ﹤0.01%
1,368
+914
+201% +$9.14K
KSI
7717
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
$14K ﹤0.01%
+1,483
New +$14.3K
OYST
7718
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$14K ﹤0.01%
829
-816
-50% -$15.5K
MDH.U
7719
DELISTED
MDH Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-half of one redeemable warrant
MDH.U
$14K ﹤0.01%
1,404
+400
+40% +$4K
IIIIU
7720
DELISTED
INSU Acquisition Corp. III Unit
IIIIU
$14K ﹤0.01%
1,435
-500
-26% -$5.04K
GTPBU
7721
DELISTED
Gores Technology Partners II, Inc. Units
GTPBU
$14K ﹤0.01%
1,387
-104
-7% -$1.05K
GBUG
7722
DELISTED
Pacer iPath Gold ETNs
GBUG
$14K ﹤0.01%
+496
New +$14.7K
HTPA
7723
DELISTED
Highland Transcend Partners I Corp.
HTPA
$14K ﹤0.01%
+1,433
New +$14.1K
LMACA
7724
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
$14K ﹤0.01%
1,398
+752
+116% +$7.68K
ASZ
7725
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$14K ﹤0.01%
+1,396
New +$13.7K

Similar funds

UBS Group's Q2 2021 Portfolio in Review

As of Q2 2021, UBS Group held 10,459 positions worth $310B, up 2.9% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $12.9B in Q2 2021, closing 927 positions and reducing 4,168 holdings. Its most notable exit was INPHI CORPORATION, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Dimensional US Core Equity 2 ETF worth $42.4M.

  • UBS Group's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 1,571,036 shares worth $42.4M.
  • UBS Group added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $1.02B increase.
  • UBS Group's biggest Q2 2021 reduction was Alibaba, cutting an estimated $2.65B.
  • UBS Group fully exited INPHI CORPORATION in Q2 2021, selling an estimated $121M.
  • UBS Group's ten largest holdings make up 15% of its $310B portfolio in Q2 2021.
  • UBS Group opened 1,343 new positions and closed 927 in Q2 2021.
  • UBS Group's portfolio value rose 2.9% quarter-over-quarter to $310B.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.